Crossref journal-article
BMJ
BMJ (239)
Bibliography

Kanis, J. A., Johnell, O., Gullberg, B., Allander, E., Dilsen, G., Gennari, C., Lopes Vaz, A. A., Lyritis, G. P., Mazzuoli, G., & Miravet, L. (1992). Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ, 305(6862), 1124–1128.

Authors 10
  1. J. A. Kanis (first)
  2. O. Johnell (additional)
  3. B. Gullberg (additional)
  4. E. Allander (additional)
  5. G. Dilsen (additional)
  6. C. Gennari (additional)
  7. A. A. Lopes Vaz (additional)
  8. G. P. Lyritis (additional)
  9. G. Mazzuoli (additional)
  10. L. Miravet (additional)
References 20 Referenced 226
  1. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102:319-24. (10.7326/0003-4819-102-3-319) / Ann Intern Med / Long-term estrogen replacement therapy prevents bone loss and fractures by Ettinger, B.; Genant, H.K.; Cann, C.E. (1985)
  2. Maclntyre I, Stevenson JC, Whitehead MI, Wimalawansa SJ, Banks LM, Healey MJR. Calcitonin for prevention of postmenopausal bone loss. Lancet 1988;1:900-2. / Lancet / Calcitonin for prevention of postmenopausal bone loss by Maclntyre, I.; Stevenson, J.C.; Whitehead, M.I.; Wimalawansa, S.J.; Banks, L.M.; Healey, M.J.R. (1988)
  3. Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in postmenopausal osteoporosis. NEnglJ Med 1990;322:1265-71. (10.1056/NEJM199005033221803) / NEnglJ Med / Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in postmenopausal osteoporosis by Storm, T.; Thamsborg, G.; Steiniche, T.; Genant, H.K.; Sorensen, O.H. (1990)
  4. Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N EnglJMed 1990;323:73-9. (10.1056/NEJM199007123230201) / N EnglJMed / Intermittent cyclical etidronate treatment of postmenopausal osteoporosis by Watts, N.B.; Harris, S.T.; Genant, H.K.; Wasnich, R.D.; Miller, P.D.; Jackson, R.D. (1990)
  5. Geusens P, Dequeker J, Verstraeten A, Nijs J. Bone response to termination of nandrolone decanoate, 1-c vitamin D3 and calcium infusion treatment in' osteoporosis. In: Christiansen C, Johansen JS, Riis BJ, eds. Osteoporosis. Copenhagen: Osteopress ApS, 1977:966-8. / Bone response to termination of nandrolone decanoate, 1-c vitamin D3 and calcium infusion treatment in' by Geusens, P.; Dequeker, J.; Verstraeten, A.; Nijs, J. (1977)
  6. Chesnut CH, Ivey JL, Gruber HE, Matthews M, Nelp WB, Sisom K. Stanozolol in post-menopausal osteoporosis: therapeutic efficacy and possible mechanism of action. Metabolismn 1983;32:571-80. (10.1016/0026-0495(83)90027-6) / Metabolismn / Stanozolol in post-menopausal osteoporosis: therapeutic efficacy and possible mechanism of action by Chesnut, C.H.; Ivey, J.L.; Gruber, H.E.; Matthews, M.; Nelp, W.B.; Sisom, K. (1983)
  7. Kanis JA, Passmore R. Calcium supplementation of the diet. BMJ 1989;298: 137-40, 205-8. (10.1136/bmj.298.6667.137) / BMJ / Calcium supplementation of the diet by Kanis, J.A.; Passmore, R. (1989)
  8. Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G. Effect of vitamin D supplementation on winter-time and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991;115:505-12. (10.7326/0003-4819-115-7-505) / Ann Intern Med / Effect of vitamin D supplementation on winter-time and overall bone loss in healthy postmenopausal women by Dawson-Hughes, B.; Dallal, G.E.; Krall, E.A.; Harris, S.; Sokoll, L.J.; Falconer, G. (1991)
  9. Ott SM, Chesnut CH. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 1989;110:267-74. (10.7326/0003-4819-110-4-267) / Ann Intern Med / Calcitriol treatment is not effective in postmenopausal osteoporosis by Ott, S.M.; Chesnut, C.H. (1989)
  10. Riggs BL, Hodgson SF, O'Fallon WM, Chao EYS, Wahner HW, Muhs JM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. NEnglJMed 1990;322:802-9. (10.1056/NEJM199003223221203) / NEnglJMed / Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis by Riggs, B.L.; Hodgson, S.F.; O'Fallon, W.M.; Chao, E.Y.S.; Wahner, H.W.; Muhs, J.M. (1990)
  11. Naessen T, Persson I, Adami H-O, Bergstrom R, Berqvist L. Hormone replacement therapy and the risk for first hip fracture. Ann Intern Med 1990;113:95-103. (10.7326/0003-4819-113-2-95) / Ann Intern Med / Hormone replacement therapy and the risk for first hip fracture by Naessen, T.; Persson, I.; Adami, H.-O.; Bergstrom, R.; Berqvist, L. (1990)
  12. Weiss NS, Carol PH, Ure L, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. NEngl3JMed 1980;303: 1195-8. / Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen by Weiss, N.S.; Carol, P.H.; Ure, L.; Ballard, J.H.; Williams, A.R.; Daling, JR (1980)
  13. Kanis JA, Geusens P, Christiansen C. Guidelines for clinical trials in osteoporosis. Osteoporosis International 1991;1: 182-8. (10.1007/BF01625451) / Osteoporosis International / Guidelines for clinical trials in osteoporosis by Kanis, J.A.; Geusens, P.; Christiansen, C. (1991)
  14. Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Osteoporosis International 1991;1: 1 14-7. / Osteoporosis International / Prophylaxis and treatment of osteoporosis by Consensus Development Conference (1991)
  15. Kanis JA. Treatment of osteoporotic fracture. Lancet 1984;i:27-33. (10.1016/S0140-6736(84)90191-0) / Lancet / Treatment of osteoporotic fracture by Kanis, J.A. (1984)
  16. Dequeker J, Tobing L, Rutten V, Geusens P, MEDOS Study Group. Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire. Clin Rheu"matol 1991;10:49-53. (10.1007/BF02208033) / Clin Rheu"matol / Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire by Dequeker, J.; Tobing, L.; Rutten, V.; Geusens, P.; Group, M.E.D.O.S.Study (1991)
  17. Hosmer D, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, 1989. / Applied logistic regression by Hosmer, D.; Lemeshow, S. (1989)
  18. Law MR, Wald NJ, Meade TW. Strategies for the prevention of hip fracture. BMJ 1991;303:453-9. (10.1136/bmj.303.6800.453) / BMJ / Strategies for the prevention of hip fracture by Law, M.R.; Wald, N.J.; Meade, T.W. (1991)
  19. Browner WS, Seeley DG, Vogt TM, Cummings SR. Non-trauma mortality in elderly women with low bone mineral density. Lancet 1991;338:355-8. (10.1016/0140-6736(91)90489-C) / Lancet / Non-trauma mortality in elderly women with low bone mineral density by Browner, W.S.; Seeley, D.G.; Vogt, T.M.; Cummings, SR (1991)
  20. Cooper C, Barker DJP, Wickham C. Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain. BMJ 1988;297: 1443-6. (10.1136/bmj.297.6661.1443) / BMJ / Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain by Cooper, C.; Barker, D.J.P.; Wickham, C. (1988)
Dates
Type When
Created 16 years, 5 months ago (March 30, 2009, 8:16 a.m.)
Deposited 4 years, 11 months ago (Sept. 26, 2020, 7 a.m.)
Indexed 2 days, 19 hours ago (Sept. 4, 2025, 10:09 a.m.)
Issued 32 years, 10 months ago (Nov. 7, 1992)
Published 32 years, 10 months ago (Nov. 7, 1992)
Published Print 32 years, 10 months ago (Nov. 7, 1992)
Funders 0

None

@article{Kanis_1992, title={Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.}, volume={305}, ISSN={1468-5833}, url={http://dx.doi.org/10.1136/bmj.305.6862.1124}, DOI={10.1136/bmj.305.6862.1124}, number={6862}, journal={BMJ}, publisher={BMJ}, author={Kanis, J. A. and Johnell, O. and Gullberg, B. and Allander, E. and Dilsen, G. and Gennari, C. and Lopes Vaz, A. A. and Lyritis, G. P. and Mazzuoli, G. and Miravet, L.}, year={1992}, month=nov, pages={1124–1128} }